000 02389 a2200697 4500
005 20250517020402.0
264 0 _c20150427
008 201504s 0 0 eng d
022 _a1460-2105
024 7 _a10.1093/jnci/djv034
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDar, Altaf A
245 0 0 _aThe role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
_h[electronic resource]
260 _bJournal of the National Cancer Institute
_cFeb 2015
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntigens, Nuclear
_xmetabolism
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aGene Dosage
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aImmunoblotting
650 0 4 _aImmunohistochemistry
650 0 4 _aIn Situ Hybridization, Fluorescence
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Nude
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aMutation
_xdrug effects
650 0 4 _aNerve Tissue Proteins
_xmetabolism
650 0 4 _aOximes
_xpharmacology
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aReal-Time Polymerase Chain Reaction
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aTranscription Factors
_xmetabolism
650 0 4 _aVemurafenib
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aNosrati, Mehdi
700 1 _aBezrookove, Vladimir
700 1 _ade Semir, David
700 1 _aMajid, Shahana
700 1 _aThummala, Suresh
700 1 _aSun, Vera
700 1 _aTong, Schuyler
700 1 _aLeong, Stanley P L
700 1 _aMinor, David
700 1 _aBillings, Paul R
700 1 _aSoroceanu, Liliana
700 1 _aDebs, Robert
700 1 _aMiller, James R
700 1 _aSagebiel, Richard W
700 1 _aKashani-Sabet, Mohammed
773 0 _tJournal of the National Cancer Institute
_gvol. 107
_gno. 5
856 4 0 _uhttps://doi.org/10.1093/jnci/djv034
_zAvailable from publisher's website
999 _c24653593
_d24653593